Cochrane Review Group
Skin
74 systematic reviews in Skin ask 1,886 questions. 28.7% have no studies to answer them, 17.3% rest on very low certainty evidence and 24.1% reach moderate or high certainty.
Reviews
74
Questions
1,886
current versions
No studies
28.7%
Moderate or high
24.1%
No studies 542 · 28.7%Ungraded 130 · 6.9%Very low 326 · 17.3%Low 434 · 23%Moderate 348 · 18.5%High 106 · 5.6%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Prednisone plus azathioprine vs prednisone Disease control (at 6 months) · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | RR 0.93 [0.52, 1.66] | 1 study · 67 participants | Very low |
Prednisone plus azathioprine vs prednisone Mortality (at 6 months) · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | RR 1.03 [0.35, 3.06] | 1 study · 67 participants | Very low |
Prednisone plus azathioprine vs prednisone Quality of life ‐ not measured · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | No studies |
Prednisone plus azathioprine vs prednisone Adverse events · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | Very low |
Nicotinamide plus tetracycline vs prednisone Disease control: complete response at 8 weeks: excluding dropouts · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | RR 2.5 [0.37, 16.89] | 1 study · 18 participants | Very low |
Nicotinamide plus tetracycline vs prednisone Mortality at 6 months · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | RR 0.18 [0.01, 3.85] | 1 study · 18 participants | Very low |
Nicotinamide plus tetracycline vs prednisone Quality of life ‐ not measured · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | No studies |
Nicotinamide plus tetracycline vs prednisone Adverse events at 1 year · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | Very low |
Methylprednisolone plus azathioprine vs methylprednisolone plus dapsone Disease control (time when steroid could be discontinued) · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | 1 study · 54 participants | Very low |
Methylprednisolone plus azathioprine vs methylprednisolone plus dapsone Mortality at 1 year · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | RR 0.33 [0.04, 3.01] | 1 study · 54 participants | Very low |
Methylprednisolone plus azathioprine vs methylprednisolone plus dapsone Quality of life ‐ not measured · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | No studies |
Methylprednisolone plus azathioprine vs methylprednisolone plus dapsone Adverse events at 1 year · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | Very low |
Reviews 74
Topical treatments for scalp psoriasis
CochraneSoF table
15 questions
Sun protection for preventing basal cell and squamous cell skin cancers
CochraneSoF table
3 questions
Interventions for acne scars
CochraneSoF table
43 questions
Interventions for rosacea
CochraneSoF table
144 questions
Safety of topical corticosteroids in pregnancy
CochraneSoF table
19 questions
Topical antifungals for seborrhoeic dermatitis
CochraneSoF table
10 questions
House dust mite reduction and avoidance measures for treating eczema
CochraneSoF table
4 questions
Complementary therapies for acne vulgaris
CochraneSoF table
3 questions
Topical tacrolimus for atopic dermatitis
CochraneSoF table
23 questions
Anti‐TNF agents for paediatric psoriasis
CochraneSoF table
5 questions
Interventions for hidradenitis suppurativa
CochraneSoF table
41 questions
Interventions for prevention of herpes simplex labialis (cold sores on the lips)
CochraneSoF table
72 questions
Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma
CochraneSoF table
7 questions
Interventions for hirsutism (excluding laser and photoepilation therapy alone)
CochraneSoF table
63 questions
Oral fumaric acid esters for psoriasis
CochraneSoF table
14 questions
H1‐antihistamines for chronic spontaneous urticaria
CochraneSoF table
26 questions
Topical anti‐inflammatory agents for seborrhoeic dermatitis of the face or scalp
CochraneSoF table
5 questions
Topical antifungal treatments for tinea cruris and tinea corporis
CochraneSoF table
36 questions
Interventions for melanoma in situ, including lentigo maligna
CochraneSoF table
5 questions
Chinese herbal medicine for atopic eczema
CochraneSoF table
17 questions
Interferon alpha for the adjuvant treatment of cutaneous melanoma
CochraneSoF table
2 questions
Narrow‐band ultraviolet B phototherapy versus broad‐band ultraviolet B or psoralen‐ultraviolet A photochemotherapy for psoriasis
CochraneSoF table
20 questions
Interventions for erosive lichen planus affecting mucosal sites
Cochranefull textintervention
55 questions
Venom immunotherapy for preventing allergic reactions to insect stings
CochraneSoF table
4 questions